3 Patents
- 0 cites
- US119395822024Antisense Oligonucleotides Targeting SCN2A for the Treatment of SCN1A Encephalopathies
Rogcon, Inc.
0 cites - US117134632023Compositions and Methods for Increasing Expression of SCN2A
The Florey Institute Of Neuroscience And Mental Health
0 cites